why choose us

First received: April 26, 2023

Clinical Trial: Effect of Nicotinic Acid as Add on Therapy in Patients Receiving ? Blocker for Prophylaxis of Moderate to Severe Migraine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Migraine Prophylaxis

Study Type: INTERVENTIONAL


Official Title: Effect of Nicotinic Acid as add-on Therapy in Patients Receiving ? Blocker for Prophylaxis of Moderate to Severe Migraine: A Randomized, Double-blind, Placebo-controlled Trial

Brief Summary: This is a prospective single center, randomized, double-blind, 3 arm placebo-controlled study in subjects with migraine headache requiring prophylactic treatment.The patients will be randomized to receive Nicotinic Acid Extended-release tablet 500 mg or 1000 mg or placebo for 12 weeks.The safety and efficacy outcome measures will be assessed at baseline and 12 weeks.

Read more